Results
143
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
143 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SCPL | US$22.94 | 0.04% | 68.7% | US$2.9b | US$22.96 | PE20.9x | E8.7% | n/a | ||
MI | US$2.93 | -65.7% | -58.1% | US$13.2m | n/a | PE2.6x | n/a | n/a | ||
GRVY | US$65.11 | -4.7% | -8.2% | US$466.1m | n/a | PE7.6x | n/a | n/a | ||
ATHM | US$28.53 | 6.6% | 5.0% | US$3.3b | US$30.14 | PE14.5x | E3.1% | 4.0% | ||
SWAG | US$1.12 | -3.2% | -9.4% | US$20.7m | n/a | PE596.1x | n/a | n/a | ||
CARG | US$35.16 | -3.9% | 66.2% | US$3.7b | US$37.88 | PS4.1x | E52.6% | n/a | ||
BZ | US$13.44 | -3.2% | -22.4% | US$5.9b | US$17.71 | PE29.9x | E21.0% | 1.2% | ||
YALA | US$4.30 | -4.2% | -27.6% | US$695.8m | US$6.10 | PE5.1x | E5.9% | n/a | ||
VTEX | US$6.28 | -4.1% | -11.3% | US$1.2b | US$10.58 | PE129.5x | E43.8% | n/a | ||
ROKU | US$68.71 | -8.6% | -27.5% | US$10.7b | US$78.13 | PS2.6x | E59.3% | n/a | ||
MITQ | US$0.62 | -2.0% | -27.1% | US$6.3m | n/a | PS0.3x | n/a | n/a | ||
PALT | US$1.75 | -5.2% | 0.3% | US$16.9m | n/a | PS1.7x | S-3.4% | n/a | ||
YELP | US$35.84 | -2.8% | -21.6% | US$2.4b | US$37.38 | PE20x | E19.7% | n/a | ||
YY | US$36.12 | 0.9% | -12.0% | US$2.1b | US$39.32 | PE7.8x | E1.6% | 2.2% | ||
IH | US$1.64 | 1.2% | -38.6% | US$85.7m | n/a | PE4.7x | n/a | 5.1% | ||
PODC | US$1.81 | 9.3% | -24.0% | US$42.3m | US$4.83 | PS0.9x | E58.8% | n/a | ||
VMEO | US$6.53 | -1.8% | 76.0% | US$1.1b | US$7.50 | PE32.6x | E14.8% | 0% | ||
MCHX | US$1.70 | -2.9% | 15.6% | US$71.9m | US$3.25 | PS1.5x | E-7.6% | 0% | ||
PUBM | US$15.25 | -6.2% | -5.6% | US$739.9m | US$20.75 | PE42.1x | E-3.2% | n/a | ||
CHR | US$2.60 | -4.8% | -23.5% | US$26.9m | n/a | PE0.8x | n/a | n/a | ||
BILI | US$19.19 | -9.8% | 37.0% | US$7.7b | US$23.19 | PS2.3x | E82.0% | n/a | ||
SKLZ | US$5.04 | -4.2% | -20.8% | US$93.5m | US$8.83 | PS0.8x | E-7.8% | n/a | ||
DUO | US$0.61 | -21.8% | n/a | US$10.4m | n/a | PS0.3x | n/a | n/a | ||
RDDT | US$136.27 | 3.2% | n/a | US$24.1b | US$112.65 | PS21.3x | E72.4% | n/a |